Delivery Order SPE2DR25D2011-SPE2DR26FADRV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,235.09 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count) with an ultimate completion date of November 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) valued at $2,856.60. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,296.30 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of July 1, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,045.64 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count packaging) with an ultimate completion date of November 7, 2025. This non-competitive, firm fixed-price delivery order was issued on November 6, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,096.43 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price contract valued at $1,362.35. This non-set-aside competitive award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,304.90 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count bottles), with a completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is located at the contractor's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $1,407.58 under firm fixed price terms. The order was competitively awarded without set-aside designation and is due for completion by October 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADRVDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,383.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count package), with an ultimate completion date of December 31, 2025. This competitively awarded, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The delivery order represents a routine pharmaceutical procurement supporting the federal medical supply chain. AmerisourceBergen's comprehensive IDC vehicle enables the supply of pharmaceutical products and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order reflects the company's ongoing role as a primary vendor for controlled and non-controlled medications essential to military healthcare operations, with the firm fixed pricing structure providing cost certainty for the government's procurement of this neurological treatment medication.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/29/25 |